The decision to discontinue SerpinPC follows the approval of Hympavzi, an antibody-based treatment designed to increase ...

Columnist G Shellye Horowitz's health issues pose challenges during her tap class, but she's resolved to find ways to keep on ...

Pfizer’s Hympavzi (marstacimab) has been approved in the European Union (EU) to prevent or reduce the frequency of bleeding episodes in adults and children, ages 12 and older, with severe hemophilia A ...

Metagenomi is preparing to initiate IND-enabling activities that seek to support MGX-001’s transition from preclinical to ...

The Coalition for Hemophilia B held its annual women’s retreat Nov. 14-17 in Alpharetta, Georgia. Initially scheduled for September, the event was postponed due to Hurricane Helene. Despite the delay, ...

Caeleb looked up to his big brother, finding comfort in his presence. As the elder sibling, Julian assumed the role of protector, his voice a beacon of reason and compassion for Caeleb in his battles ...

A delayed diagnosis is common for people with acquired hemophilia A (AHA), according to a new study that found that it took ...

My wife, Cazandra, had complicated surgery last week that required her to spend some time in the hospital, followed by at least two weeks of inpatient rehabilitation. We were in shock, as we’d thought ...

As a woman with hemophilia, one of the greatest challenges I face is being believed. This challenge is multifaceted. First, I ...